consequences of DNA repair changes are, obviously, genetic in nature but may be manifested as cancer or immune-deficiencies. Has the time come to screen patients for DNA repair deficiencies?
TYPES OF DNA DAMAGE AND THEIR EFFECTS
Mutagens and carcinogens exert their effects by interaction with DNA (Table 1) .1-18 Many agents induce more than one lesion in DNA, e.g. ionizing radiation causes base-modification, base loss leading to base-free sites [apurinic/apyrimidinic (AP) sites], strand breakage and cross-links.
DNA lesions may be broadly divided into:
1. Directly rniscoding modifications to the bases, e.g. conversion of cytosine to uracil, which is read as thymine 2. Non-coding modifications, e.g, loss of bases leading to AP sites 3. Lethal modifications, e.g. conversion of adenine to 3-methyladenine which blocks the movement of DNA polymerase along the DNA template A directly miscoding modification of a base converts it to a form read as a different base by the DNA polymerase, which potentially (though not always, since the genetic code is degenerate) leads to a different amino-acid being encoded. Indirectly miscoding lesions cause the polymerase to insert an inappropriate base as it passes the site. This happens at AP sites, which are non-coding but relaxation of replication fidelity apparently allows by-pass of the lesion and the DNA polymerase inserts mainly adenine opposite the non-coding site (reviewed in references 2 and 7). As AP sites can be formed from loss of any base this will lead to mutations. Lethal modifications prevent the polymerase from copying DNA-for example, covalent crosslinks between strands are generally considered lethal unless corrected. t cross-links may occur between strands or between DNA and protein t strand breaks can be single or double stranded AP = Apurinic/apyrimidinic; UV = ultraviolet.
Finally, it is likely that certain lesions affect the interaction of factors binding to DNA, such as transcription factors, which could result in inappropriate changes in gene expression.
MECHANISMS AND ENZYMOLOGY OF DNA REPAIR
Cells have evolved a wide variety of systems to repair damaged DNA (reviewed in references 1-7, and see Tables 2 and 3 and Fig. 1 ). Cells repair actively expressed genes more assiduously than inactive regions of their DNA and appear to tolerate a small level of residual damage.P-" Most of our knowledge about DNA repair has been acquired from microbial model systems, which have provided a conceptual framework for the study of man and other mammals where repair activities are generally present at far lower levels. The simplest method of repair is direct reversal of the damage, such as in the removal of alkyl groups from the 0 6 -and 04-positions of guanine and thymine, respectively, by alkyltransferase, and in the photoreactivation of UV-induced pyrimidine dimers by photo-reactivating enzyme.
Excision repair (see Fig. 1 ) exploits the complementary double-stranded nature of DNA. The damaged strand is incised at or near the lesion, a DNA fragment which includes the damage is excised, and a patch of new DNA is synthesized by using the opposite strand as a template which is then ligated together with the old.
DNA glycosylases and AP-endonucleases are monomeric globular proteins of M, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] kD which require no co-factors. They vary in substrate specificityin that they may act on individual lesions or on a group of lesions; some enzymes are combined DNA glycosylases and APendonucleases. DNA glycosylases cut the basesugar bond of modified bases to release the altered base in free form; AP-endonucleases cut the sugar-phosphate backbone at AP sites.
E coli UvrABC excinuclease is a large (c. 400 kD) multi-subunit enzyme which recognizes a large number of bulky adducts to DNA bases as well as the UV-photoproducts. It requires several co-factors including Mg2 + and ATP. The homologous system in man is probably faulty in xeroderma pigmentosum (see below).
Strand breaks are generated in a number of ways (Table 1) and are obligatory intermediates in excision repair. Double-strand breaks are responsible for chromosome aberrations induced by ionizing radiation (reviewed in reference 5). The repair of double strand breaks and some of the single strand breaks occur through recombination mechanisms.
The conversion of the ends at strand breaks (whether caused by damage or through the action of AP endonucleases) into good primers for DNA polymerase and ligase involves the action of a number of enzymes which can remove either inappropriate phosphate or hydroxyl groups or deoxyribose moieties without a cyclic base.
Mismatched bases are also repaired. Another process, 'post-replication repair' or 'daughterstrand gap repair' involves interchange of strands and is really a by-pass mechanism for dealing with gaps generated in daughter strands when advancing DNA replication forks encounter ACQUIRED AND INHERITED DNA REPAIR DEFICIENCY No disease caused by an acquired DNA repair deficiency has been described. There is no Bloom's syndrome Bloom's syndrome (BS) is a rare, autosomally inherited recessive disorder, characterized by small birth weight and body size, immunosuppression and high risk of cancer. [24] [25] [26] It was first described in 1954 by Bloom, a New York paediatrician, as a 'congenital telangiectatic erythema resembling lupus erythematosus in dwarfs"." To date just over 100 cases are known world wide; it is present in all racial groups. About 1070 of Ashkenazy Jews appear to be heterozygotes. Nearly 30% of the known cases have developed cancer of different types.
Cells from BS patients are characterized by chromosome aberrations but also have slower cycling times, show delayed DNA replication with accumulation of intermediate forms and accumulation of DNA strand breaks. 6 ,27,28 Cells from BS patients have a defect in the action of the enzyme DNA ligase 1,27-29 Sequence analysis of the gene coding for this enzyme has shown that in one case the deficiency is due to two different mis-sense mutations in different alleles.!? Further studies are needed to resolve whether the defects are confined to the ligase enzyme. evidence that ageing and senescence relate to failure of DNA repair.
Carcinogenesis, however, is a multistep process. Mutations are more likely to occur in a cell which is a defective in its DNA repair armoury. Certain rare inherited disorders have been described which are characterized by increased sensitivity to radiation and carcinogens and associated with an increased incidence of cancers occurring earlier in life. 23 These include Bloom's syndrome, xeroderma pigmentosum, ataxia telangiectasia, basal cell naevus syndrome, Cockayne's syndrome and Fanconi's anaemia, of which the best understood at the molecular level are Bloom's syndrome and xeroderma pigmentosum.
Xeroderma pigmentosum
Kaposi described xeroderma pigmentosum (XP) in 1882 as an inherited disorder associated with skin tumours in young patients on those portions of their bodies exposed to sunlight.!' These patients are also severely photo-sensitive. XP is a rare autosomal recessive disorder (frequency c. 1 in 250 000) with a marked genetic heterogeneity.32 Cells of affected patients show a decreased rate of removal of pyrimidine dimers and a variety of chemical adducts including those from cisplatinum, from damaged DNA. This defect is lesions. Thus, it is not a repair process because the lesions still have to be excised subsequently. Ligation of DNA by covalent closure (Fig. 1 ) is a feature both of the last stage of excision repair and of recombinational events, including rearrangement of immunoglobulin genes.!' Errors at this stage will produce a complex clinical picture such as that seen in Bloom's syndrome (see below).
Dividing cells respond to DNA damage by inhibiting their progression through the cell cycle so that they have time to repair their DNA before replication, thus limiting the mutagenic effect of damage. This control appears to be mediated by the anti-oncogene p53. 22 FIGURE 1. Scheme for base excision repair of DNA damaged by ionizing radiation or an oxygen derivedfree radical such as OH·. The complementary strand is not shown. The sequence is written in the traditional 5 ' associated with an inability to incise damaged DNA as part of the repair process. 32 ,33 The system used in human UV-repair appears to be akin to the bacterial multi subunit UvrABC excinuclease (see Tables 1 and 3 ).3,6.7.33 There are a large number of complementation groups for XP and recently candidate genes for certain groups (A, B and D) , whose predicted products have features of other DNA interacting proteins, have been described. 34.35 Cockayne's syndrome Cockayne's syndrome (CS) is another inherited disorder with sensitivity to sunlight but instead of the skin lesions (including cancers) of XP the patients suffer mental and physical retardation and skeletal deformities. Current work indicates that CS could be due to mutations of different components of the XP system 35.36 (reviewed in reference 7) . Further studies of this syndrome and the even rarer trichothiodystrophy are needed to assess the role of repair.
Fanconi's anaemia Patients with Fanconi's anaemia have progressive pancytopenia and cellular hypersensitivity to DNA cross-linking agents. The disorder is inherited as an autosomal recessive condition, four genetic complementation groups have been identified and the cDNA for the putative gene of one of the complementation groups has recently been cloned."
DOES INCREASED REPAIR PROFICIENCY CAUSE RESISTANCE TO CHEMOTHERAPEUTIC AGENTS?
Several DNA repair processes correct the damage caused by chemotherapeutic agents. The repair function involved in XP can deal with the DNA damage caused by cis-platinum.P Crosslinking of DNA by chloroethylnitrosoureas, of which bischloroethylnitrosourea (BCNU) is used clinically, is prevented by 06methylguaninemethyltransferase. It does not prevent crosslinking by nitrogen mustards.s" The ubiquitous DNA repair enzyme uracil-DNA glycosylase excises not only uracil but all other uracil analogues tested, including the chemotherapeutic agent 5-fluorouracil (at 5OJo of the rate of uracil). 1, 2 Although most cases of induced resistance to chemotherapeutic agents appear to be related to the multiple drug resistance phenomenon and gene amplification, it is possible that the survival of malignant cells or emergence of drug-resistant clones could be a result of enhanced DNA repair . There have been reports that resistance to cisplatinum therapy is caused by increased repair proficiency ('super-repair').39
METHODS OF ASSESSING DNA REPAIR PROFICIENCY
DNA repair proficiency, like any other enzymic activity, may either be assessed directly or inferred by immunological or molecular genetic methods.
Direct measurement of activity Direct measurement of human DNA repair activity is not a routine clinical biochemistry procedure because of the methods involved. DNA repair enzymes are present at very low levels'? and skin biopsies or peripheral blood samples do not yield sufficient material without in vitro culture. Preparation of enzyme extracts is also a skilled operation. The substrates are not commercially available and usually need to be radioactively labelled. The products of the reactions are isolated and identified by either paper chromatography or HPLC (thin-layer chromatography having generally proved unsuitable), or by gel electrophoresis, and usually quantified by (j-scintillation counting. In special cases spectrofluorimetry (for 06-methylguanine), electrochemical detection (8-oxoguanine) and combined gas-chromatography with massspectrometry after derivatization have been used (reviewed in references 1-5 and 15).
Immunological detection of enzyme
This method for assessing repair functions has all the drawbacks of any antibody-based method for determining an enzyme system. For example, the antibody does not necessarily differentiate between active and inactive forms of the enzyme, and might also pick up proteolytic fragments.
Molecular genetic techniques
Molecular genetic analysis can assess the integrity of the gene encoding a repair activity. Accurate analysis (to the level of a single base pair change) and also the use of polymerase chain reaction (PCR) analysis requires the sequence to be known. Once a particular mutation has been characterized its presence or absence can be determined comparatively easily.
Analysis of DNA, however, cannot determine whether a gene is expressed. Consequently, the mRNA levels need to be determined, and RNA is Breimer unstable. In situ hybridization of biopsy samples such as skin fibroblasts is an alternative approach but does not determine whether the gene product is active." It is also a highly specialised and difficult technique.
Molecular genetic procedures can confirm a provisional diagnosis of a recognized syndrome and this gives them an obvious role in genetic counselling, ante-natal screening and preimplantation diagnosis.
PRACTICAL CONSIDERATIONS
In an area with a catchment population of 500 ()()() and a low incidence of cancer, the radiotherapy department may deal with 1000 new patients per year while the chemotherapy department may see 300. As overloading of the body's DNA repair and defence systems can increase the risk of cancer it might be beneficial to assess the patient's repair status before instigating treatment or diagnostic techniques involving potentially mutagenic or carcinogenic modalities.
Epidemiological studies on the effects of ionizing radiation (the first environmental agent shown to cause mutations)? indicate that high dose exposure (such as from atomic bombs and radiotherapy) is associated with an increased incidence of cancer, mainly haematological, breast, thyroid and lung. 42 An annual excess risk of 3·4 to nine cases per million persons per rad has been estimated. Few, if any, modern diagnostic procedures use such high levels of exposure (most are in the millirad range, although special investigations such as barium enemas have higher doses). High, but not low, doses of radiation to the foetus early in pregnancy (3-17 weeks) are particularly associated with a high incidence of microcephaly, mental and growth retardation and specific lesions. There is, however, evidence that irradiation of the early conceptus or exposure to chemical carcinogens results in genetic changes propagated in the germline. The conclusion that low radiation doses fail to show evidence of a significant increase in risk is being reviewed."
Epidemiological data has not identified any sub-group particularly prone to the effects of radiation, but it should be remembered that these studies were not designed to investigate such a hypothesis. Moreover, the vast majority (88010) of ionizing radiation to which we are exposed is background radiation and therefore unavoidable.P Ionizing radiation acts through the formation of oxygen free radicals, in particular the hydroxyl radical. 12 ,18 Such reactive forms are Ann Clin Biochem 1993: 30 also a by-product of normal aerobic metabolism and are dealt with by a large number of complex and overlapping repair and detoxification processes. 5 ,10-16, 18 Indeed, complete inability to deal with this type damage is probably not compatible with life.
Although use of chemotherapy depends on the individual physician's assessment of the role of palliative versus curative chemotherapy most cancer chemotherapy is given in a 'nochoice' situation. However, if there were to be a recurrence of the tumour, then assessment of the DNA repair proficiency could provide a guide to the best therapy.
When treating disorders that may not be lifethreatening, such as psoriasis with UV-irradiation and psoralen (PUVA treatment), the benefits of screening could be greater. About 2010 of the population is affected with psoriasis. Several epidemiological studies have shown an increase in the incidence of squamous cell carcinoma of the skin, and possibly colonic cancer, in patients treated with PUVA. 44 One recent Swedish study of 4799 patients followed up for 7 years showed a dose-dependent increase (30 times for 200 treatments) in the risk of squamous cell cancer of the skin." The study also reported an increase in respiratory cancer in men and women, together with an increase in pancreatic cancer among men and kidney cancer among women, a sex difference which is not easy to explain. 44 ,45 Further studies are required to define any role of DNA repair impairment in the side-effects of PUVA treatment.
CONCLUSIONS
The assessment of human DNA repair status is at present a specialist skill available only in a few research centres. Epidemiological and practical considerations would suggest that assessment can safely be limited to certain sub-groups. Direct assessment of enzymatic activities is currently not a routine laboratory procedure; it is also expensive. At present the potential benefits are too few to justify the general introduction of these tests. However, a leap in technology could bring DNA repair to the District General Hospital.
